No De-escalation of Therapy for HPV+ Throat Cancer No De-escalation of Therapy for HPV+ Throat Cancer

De-escalating therapy by using cetuximab with radiotherapy did not improve side effects and, more importantly, had worse survival compared with chemoradiotherapy for patients with good prognosis HPV+ throat cancers.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news